Antiplasmodial activity of sulfonylhydrazones: in vitro and in silico approaches

Future Med Chem. 2021 Feb;13(3):233-250. doi: 10.4155/fmc-2020-0229. Epub 2020 Dec 9.

Abstract

Malaria is still a life-threatening public health issue, and the upsurge of resistant strains requires continuous generation of active molecules. In this work, 35 sulfonylhydrazone derivatives were synthesized and evaluated against Plasmodium falciparum chloroquine-sensitive (3D7) and resistant (W2) strains. The most promising compound, 5b, had an IC50 of 0.22 μM against W2 and was less cytotoxic and 26-fold more selective than chloroquine. The structure-activity relationship model, statistical analysis and molecular modeling studies suggested that antiplasmodial activity was related to hydrogen bond acceptor count, molecular weight and partition coefficient of octanol/water and displacement of frontier orbitals to the heteroaromatic ring beside the imine bond. This study demonstrates that the synthesized molecules with a simple scaffold allow the hit-to-lead process for new antimalarials to commence.

Keywords: Plasmodium falciparum; antimalarial activity; chloroquine-resistant strains; molecular modeling; structure–activity relationship (SAR); sulfonylhydrazone derivatives.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimalarials / chemistry
  • Antimalarials / pharmacology*
  • Cell Line
  • Cell Survival / drug effects
  • Chloroquine / pharmacology
  • Chloroquine / therapeutic use
  • Drug Resistance / drug effects
  • Humans
  • Hydrazones / chemistry*
  • Hydrazones / pharmacology
  • Life Cycle Stages / drug effects
  • Machine Learning
  • Malaria / drug therapy
  • Parasitic Sensitivity Tests
  • Plasmodium falciparum / drug effects*
  • Plasmodium falciparum / growth & development
  • Quantum Theory
  • Structure-Activity Relationship

Substances

  • Antimalarials
  • Hydrazones
  • Chloroquine